VivePeptides logo

Research Use Only

GLP-1 Peptides

GLP-1 receptor agonists and multi-incretin research peptides studied for glucose-dependent insulin signaling and satiety pathways.

GLP-1 Peptides are research compounds studied for their interactions with glucagon-like peptide-1 receptors and related incretin receptor systems. This category encompasses selective GLP-1 receptor agonists, dual GLP-1/GIP receptor agonists, and triple GLP-1/GIP/glucagon receptor agonists. Featured compounds include Semaglutide, Tirzepatide, and Retatrutide, each available from VivePeptides as research-grade material for laboratory investigation only.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

Vive GLP(S) research peptide vial

Vive GLP(S)

$75.00View
Vive GLP(T) research peptide vial

Vive GLP(T)

$75.00View
Vive GLP(R) research peptide vial

Vive GLP(R)

$75.00View

Research Overview

GLP-1 Peptides: A Research Category Spanning the Incretin Receptor Agonism Spectrum

The GLP-1 peptide category encompasses research compounds that engage glucagon-like peptide-1 receptors, GIP receptors, or glucagon receptors, either selectively or in combination. This receptor family has become a highly active area of investigation in preclinical metabolic research, with published literature examining receptor binding kinetics, downstream signaling cascades, and in vitro cellular response profiles. Each compound within this collection occupies a distinct position on the receptor agonism spectrum, from monoagonism through triagonism.

Semaglutide is a selective GLP-1 receptor agonist, studied in models of receptor occupancy and cAMP-mediated signaling. Tirzepatide is a dual GLP-1/GIP receptor agonist, investigated in preclinical literature for additive or synergistic receptor engagement. Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist, the most pharmacologically complex compound in this group.

VivePeptides supplies each compound as research-grade material, documented with third-party analytical data, for use in controlled laboratory settings only.

Single, Dual, and Triple Receptor Classes

This collection spans three distinct receptor agonism profiles, allowing researchers to compare GLP-1 pathway engagement at varying levels of receptor complexity within a single supplier source.

Third-Party Purity and Analytical Documentation

Each GLP-1 peptide is supplied with HPLC purity data and mass spectrometry confirmation, providing the analytical documentation necessary for reproducible preclinical research protocols.

Matching Compounds to Study Design

Researchers select among Semaglutide, Tirzepatide, and Retatrutide based on the specific receptor targets and signaling pathways required by their experimental model, not interchangeably.

Compound Comparison

How these compounds compare

CompoundMechanism ClassResearch FocusDistinguishing Feature
SemaglutideSelective GLP-1 receptor agonistGLP-1 receptor binding, cAMP signalingSingle-receptor selectivity
TirzepatideDual GLP-1/GIP receptor agonistCombinatorial incretin receptor engagementCo-activation of two receptor types
RetatrutideTriple GLP-1/GIP/glucagon receptor agonistMulti-receptor metabolic signalingThree-receptor polyagonism profile

Mechanism & Research Context

Mechanism Classes and Preclinical Research Context for GLP-1 and Incretin Peptides

What distinguishes the compounds in this collection is the degree of receptor polyagonism each represents. Semaglutide operates as a selective GLP-1 receptor agonist, and preclinical literature has examined its receptor binding affinity, half-life profile, and intracellular signaling through adenylyl cyclase pathways.

Tirzepatide introduces dual agonism at GLP-1 and GIP receptors, and published in vitro and in vivo research has investigated whether combinatorial receptor engagement produces distinct signaling outcomes compared to single-receptor agonists. Retatrutide adds glucagon receptor activity to the GLP-1/GIP receptor profile, making it a subject of investigation in models where all three receptor systems are relevant to the signaling question under study.

Researchers selecting between these compounds typically do so based on receptor specificity requirements, the signaling pathway under investigation, and the experimental model being used. All three compounds require appropriate cold-chain handling and reconstitution protocols consistent with lyophilized peptide research materials.

Research FAQ

Frequently asked questions

What are GLP-1 peptides in the context of laboratory research?

GLP-1 peptides are research compounds studied for their ability to engage glucagon-like peptide-1 receptors and, in some cases, related incretin receptors including GIP and glucagon receptors. In preclinical literature, this compound class has been investigated for receptor binding kinetics, intracellular signaling through cAMP-dependent pathways, and comparative pharmacological profiles across receptor subtypes. These materials are supplied by VivePeptides strictly for controlled laboratory research and are not intended for human or animal administration.

What is the difference between Semaglutide, Tirzepatide, and Retatrutide?

Semaglutide is a selective GLP-1 receptor agonist, Tirzepatide is a dual GLP-1/GIP receptor agonist, and Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist, reflecting progressively broader receptor engagement profiles. These distinctions are the central variable researchers consider when selecting between compounds, since each targets a different combination of receptors in the incretin and related signaling axis. The appropriate compound depends on the receptor specificity and signaling pathway relevant to the experimental design.

What research applications are GLP-1 and incretin peptides investigated for in preclinical studies?

GLP-1 and incretin peptides are investigated in preclinical research examining receptor binding affinity, cAMP-mediated intracellular signaling, and comparative receptor pharmacology across GLP-1, GIP, and glucagon receptor systems. Published literature has studied these compounds in cell-based assays and in vivo preclinical models focused on metabolic receptor biology and receptor cross-talk. All such research is conducted in controlled laboratory settings, and VivePeptides supplies these materials exclusively for that purpose.

Why is the glp 1 peptide category considered an active area of preclinical investigation?

The GLP-1 peptide category is an active area of preclinical investigation because it encompasses multiple receptor agonism classes, from monoagonism to triagonism, that allow researchers to probe distinct signaling outcomes within the same receptor superfamily. The availability of compounds like Semaglutide, Tirzepatide, and Retatrutide creates a comparative framework for studying how receptor specificity and polyagonism influence downstream signaling in experimental models. This receptor diversity makes the category particularly valuable for mechanistic research into incretin receptor biology.

How should GLP-1 research peptides be stored and handled in a laboratory setting?

GLP-1 research peptides require cold-chain storage conditions and should be maintained at temperatures specified in the product documentation to preserve structural and chemical integrity. Reconstitution should follow established laboratory protocols appropriate for lyophilized peptide materials, including use of suitable buffers and aseptic technique. VivePeptides provides analytical data with each compound to support informed handling decisions in research environments.

What makes Retatrutide distinct from other GLP-1 peptides in this collection?

Retatrutide is distinct because it is a triple receptor agonist that engages GLP-1, GIP, and glucagon receptors simultaneously, a profile not shared by Semaglutide or Tirzepatide. Preclinical research has examined this multi-receptor engagement in models where all three receptor systems are co-expressed or co-relevant to the signaling question under investigation. This makes Retatrutide the most pharmacologically complex compound in this collection and the appropriate selection when glucagon receptor activity is a required variable in the study design.

Related Research Collections

Continue exploring

Peptides for Weight LossPeptides for Fat BurningPeptides for Muscle GrowthGrowth Hormone Peptides

All products are sold strictly for laboratory and scientific research use only. Not for human or animal consumption, diagnostic, or therapeutic use. Nothing on this page constitutes medical advice or a health claim.